Life science intelligence at your fingertips
BenevolentAI is a clinical-stage, AI-enabled drug discovery and development company listed on Euronext Amsterdam. Founded in 2013, the company uses its proprietary Benevolent Platform — built on a decade of investment in knowledge graphs and ontologies — to integrate life science data and augment scientific decision-making. Headquartered in London with offices in Cambridge and New York, BenevolentAI partners with pharmaceutical companies and pursues its own pipeline for complex diseases.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2018
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
